SEC Comment Letter 0000000000-23-011338 to Burning Rock Biotech Ltd (BNR)

Burning Rock Biotech Ltd
Date: Oct. 17, 2023 · CIK: 0001792267 · Accession: 0000000000-23-011338

View on Edgar

AI Filing Summary & Sentiment

Sentiment

Urgency

Document Type

Confidence

SEC Posture

Company Posture

Summary

Reasoning

File numbers found in text: 001-39316

Date

October 17, 2023

Author

Leo Li

Form

UPLOAD

Company

Burning Rock Biotech Ltd

Letter

United States securities and exchange commission logo October 17, 2023 Leo Li Chief Financial Officer Burning Rock Biotech Limited No. 5, Xingdao Ring Road North International Bio Island, Guangzhou, 510005 People’s Republic of China Re:Burning Rock Biotech Limited Form 20-F for the Fiscal Year Ended December 31, 2022 File No. 001-39316 Dear Leo Li: We have completed our review of your filing. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Sincerely, Division of Corporation Finance Disclosure Review Program

Show Raw Text

United States securities and exchange commission logo
October 17, 2023
Leo Li
Chief Financial Officer
Burning Rock Biotech Limited
No. 5, Xingdao Ring Road North
International Bio Island, Guangzhou, 510005
People’s Republic of China
Re:Burning Rock Biotech Limited
Form 20-F for the Fiscal Year Ended December 31, 2022
File No. 001-39316
Dear Leo Li:
            We have completed our review of your filing. We remind you that the company and its
management are responsible for the accuracy and adequacy of their disclosures, notwithstanding
any review, comments, action or absence of action by the staff.
Sincerely,
Division of Corporation Finance
Disclosure Review Program

SecProbe.io